Immunization of mice with Plasmodium berghei or Plasmodium yoelii synthetic linear peptide chimeras (LPCs) based on the circumsporozoite protein protects against experimental challenge with viable sporozoites. The immunogenicity of LPCs is significantly enhanced by spontaneous polymerization. To better understand the antigenic properties of polymeric antimalarial peptides, we studied the immune responses elicited in mice immunized with a polymer or a monomer of a linear peptide construct specific for P. yoelii and compared the responses of antigen-presenting cells following incubation with both peptide species. Efficient uptake of the polymeric peptide in vitro resulted in higher expression of the coactivation markers CD80, CD40, and CD70 on dendritic cells and higher proinflammatory cytokine production than with the monomeric peptide. Macropinocytosis seems to be the main route used by polymeric peptides internalized by antigen-presenting cells. Spontaneous polymerization of synthetic antimalarial-peptide constructs to target professional antigen-presenting cells shows promise for simple delivery of subunit malaria vaccines.Malaria is globally the most devastating vector-borne disease, responsible for more than 1 million fatalities annually (37). Malaria is also one of the most deadly transmissible diseases (6). The development of a safe and effective malaria vaccine remains an urgent, yet unmet, medical need for vast populations living in areas of endemicity (6, 39). Although revived interest in malaria research and vaccine development has recently inspired a wave of clinical trials with some promising vaccine candidates, an ideal formulation remains a distant prospect (15, 39). The lack of surrogate markers to predict protection and the complexity of the parasite life cycle have hindered the development of effective vaccines. Epidemiological and clinical evidence from vaccine trials suggest that an ideal malaria vaccine should include several antigens (14, 16). However, the inclusion of multiple antigens in a single vaccine formulation is logistically challenging and requires the use of efficient delivery systems. We have used polymeric linear peptide chimeras (LPCs) as a simple and efficient alternative to deliver subunit vaccines (8,36).Proof-of-principle studies confirmed that immunization with LPCs containing circumsporozoite protein sequences elicited protection against malaria challenge using Plasmodium berghei and Plasmodium yoelii rodent malaria models (8, 36). LPCs are synthetic linear peptides that contain a Plasmodium promiscuous CD4 ϩ T-cell epitope synthesized in tandem with B-cell and cytotoxic T-lymphocyte (CTL) epitopes. A distinguishing feature of LPCs is the inclusion of amino-and carboxyl-terminal cysteine residues that form cross-linkages for spontaneous polymerization. This results in an array of homopolymeric peptide species, easily confirmed using mass spectroscopy (8). Peptide homopolymerization is critical for antigenicity and immunogenicity (8).To better understand the protective eff...